{"nctId":"NCT01131312","briefTitle":"Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)","startDateStruct":{"date":"2008-02-20","type":"ACTUAL"},"conditions":["Cervical Intraepithelial Neoplasia"],"count":5060,"armGroups":[{"label":"Cytology","type":"EXPERIMENTAL","interventionNames":["Device: Thinprep"]},{"label":"Human Papillomavirus (HPV)","type":"EXPERIMENTAL","interventionNames":["Device: Hybrid capture 2"]},{"label":"Colposcopy","type":"EXPERIMENTAL","interventionNames":["Procedure: Colposcopy"]}],"interventions":[{"name":"Thinprep","otherNames":[]},{"name":"Hybrid capture 2","otherNames":[]},{"name":"Colposcopy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"* Inclusion Criteria:\n\n  * Diagnosis of atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL)\n  * 18 years or older\n  * Able to give informed consent with reasonable likelihood of follow-up\n\nExclusion Criteria:\n\n* Previous Hysterectomy\n* History of excisional or ablative treatment of cervix, such as laser treatment, radiation therapy, cauterization (burning), freezing or surgery such as cone biopsy or loop electrosurgical excision procedure (LEEP).\n* Already known to be pregnant\n* Already known to be human immunodeficiency virus (HIV) positive (HIV may negatively affect the clinical history of human papillomavirus (HPV), making triage less appropriate.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Cervical Intraepithelial Neoplasia III (CIN III)","description":"A cervical exam, pap test, human papilloma virus (HPV) deoxyribonucleic acid (DNA) test, and/or colposcopy was performed to detect whether or not a participant had CINIII. CINIII is defined as moderate or severe dysplasia or abnormal cells located on the cervix that can lead to cancer.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.93","spread":null},{"groupId":"OG001","value":"10.25","spread":null},{"groupId":"OG002","value":"10.84","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Cumulative Detection of Clinical Center Histologically Confirmed Cervical Intraepithelial Neoplasia 2 (CIN2) and Above (High Grade Lesion) Over the 2 Years of the Trial.","description":"Cumulative detection of CIN2 and above was assessed by pathologists who reviewed specimens from cervical pelvic exams (i.e. thin prep pap test, Human papillomavirus (HPV) Deoxyribonucleic acid (DNA) test, and/or colposcopy). Pathologists graded the specimens from CIN2 (moderate grade lesion) to CIN3 (high grade lesion).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.69","spread":null},{"groupId":"OG001","value":"18.12","spread":null},{"groupId":"OG002","value":"20.75","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":1839},"commonTop":[]}}}